Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ping Zhan
Observed name:
Zhan, Ping
Institutions:
Nanjing General Hospital of Nanjing Military Command,
Nanjing University
Observed institutions:
Nanjing University of Chinese Medicine,
Nanjing General Hospital of Nanjing Military Command,
Nanjing Drum Tower Hospital,
Nanjing Jiangning Hospital,
Southeast University,
Nanjing Medical University,
Nanjing University
show all 7
ORCID:
0009-0001-3030-2662
Observed ORCID:
0009-0001-3030-2662
OpenAlex ID:
A5028499760
The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials
2019
·
written on behalf of AME Lung Cancer Collaborative Group
, Yangyang Xu
, et al.
·
Translational Lung Cancer Research
·
181
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma
2023
·
Qian Wang
, Chunwei Xu
, et al.
·
Thoracic Cancer
·
28
PDF
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
2022
·
Chunwei Xu
, Lu Si
, et al.
·
Thoracic Cancer
·
18
PDF
Expert consensus on the diagnosis and treatment of RET gene fusion non‐small cell lung cancer in China
2023
·
Xingxiang Pu
, Chunwei Xu
, et al.
·
Thoracic Cancer
·
14
PDF
Comparison of autofluorescence and white-light bronchoscopies performed with the Evis Lucera Spectrum for the detection of bronchial cancers: a meta-analysis
2020
·
written on behalf of the AME Lung Cancer Collaborative Group
, Shuangshuang Sun
, et al.
·
Translational Lung Cancer Research
·
14
PDF
First‐line chemoimmunotherapy for patients with small‐cell lung cancer and interstitial lung abnormality: CIP risk and prognostic analysis
2024
·
Yu Li
, Yuxin Jiang
, et al.
·
Thoracic Cancer
·
11
PDF
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration
2025
·
Huijing Feng
, Yang Xia
, et al.
·
Cancer Biology and Medicine
·
8
PDF
Intrapleural anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer with malignant pleural effusion: a prospective, single-arm, single-center, phase I trial
2025
·
Yuting Cui
, Qiuxia Wu
, et al.
·
Clinical & Translational Oncology
·
5
Expert consensus on the detection and clinical application of tumor mutational burden
2026
·
Zhenying Guo
, Chunwei Xu
, et al.
·
Cancer Biology and Medicine
·
4
PDF
Antibody-drug conjugates outperform chemotherapy in EGFR-TKI-resistant NSCLC: a Bayesian network meta-analysis
2025
·
Yueying Chen
, Yanjun Du
, et al.
·
Therapeutic Advances in Medical Oncology
·
3
Elevated Exosome-derived Mirnas Predict Osimertinib Resistance in Non-small Cell Lung Cancer
2020
·
Xinying Li
, Cen Chen
, et al.
·
Research Square
·
2
PDF
Expert consensus on immune checkpoint inhibitors for non-small cell lung cancer
2026
·
Danru Zheng
, Chunwei Xu
, et al.
·
International Open Medical Journal (IOMJ)
·
1
Expert consensus on the diagnosis and treatment of EGFR gene mutation non-small cell lung cancer
2026
·
Rui Meng
, Chunwei Xu
, et al.
·
International Open Medical Journal (IOMJ)
PDF
[Advances in hydrogel-based delivery of STING agonists for cancer therapy].
2026
·
Lu Chen
, Ping Zhan
, et al.
·
PubMed
Expert consensus on the diagnosis and treatment of germ cell tumors of the mediastinum
2026
·
Qing Ji
, Yue Hao
, et al.
·
International Open Medical Journal (IOMJ)
PDF
Show more works
View as search
Works count:
20
Citation count:
289
H-index:
7
I10-index:
6
Year
Topic
Type